MRF Breakthrough Consortium Welcomes Fox Chase Cancer Center
September 2, 2020Washington, DC, September 2, 2020 – The Melanoma Research Foundation (MRF) is pleased to announce that Fox Chase Cancer Center has been selected as the newest member of the MRF Breakthrough Consortium (MRFBC). Founded in 2010, the MRFBC is a nationwide …
Meet the Doctor: Dr. Vernon Sondak
August 31, 2020Meet Dr. Vernon Sondak! This year the MRF is excited to have Dr. Sondak participate in our 2020 Virtual Pediatric Melanoma Summit from September 21-25, 2020 to help spread awareness about pediatric melanoma. Get to know more about him below! Dr. Sonda …
What is Pediatric Melanoma?
August 31, 2020Guest blog by Vernon Sondak, MD and Jane L. Messina, MD from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. Dr. Sondak will be presenting at our 2020 Virtual Pediatric Melanoma Summit. Pediatric melanoma is defined as a mal …
FDA Approves Foundation Medicine’s FoundationOne Liquid CDx, a Comprehensive Pan-Tumor Liquid Biopsy Test
August 28, 2020Washington, DC, August 28, 2020 – This week, the U.S. Food and Drug Administration (FDA) approved Foundation Medicine, Inc.’s comprehensive pan-tumor liquid biopsy test called FoundationOne Liquid CDx. This test analyzes more than 300 genes and genomic …
FDA Approves Atezolizumab to Treat BRAF V600 Unresectable or Metastatic Melanoma
July 31, 2020Washington, DC, July 31, 2020 – On July 30, 2020, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.) in combination with cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresec …
Recent Comments